Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biproxi

Explore full profile

An end to end marketing platform built for and by commercial real estate middle market brokers

New York City, United StatesFounded 2018Real Estate
Valuation $0–100M Latest valuation · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biproxi and the history behind them.

About Biproxi

Biproxi operates as a multifaceted online platform focused on the commercial real estate (CRE) sector, specifically targeting the middle market. Founded in 2018 by a team of industry veterans—Gordon Smith, Yan Khamish, Thatcher Milholland, and Carrington Guy—many of whom were former executives at the competing marketplace Ten-X, the company was established to address inefficiencies in a historically fragmented market. The founders leveraged their experience at Ten-X to create a platform that consolidated various tools onto a single, more accessible interface, aiming to streamline the transaction process for brokers, buyers, and sellers.

Read full description

The firm's business model has evolved since its inception. Initially launched as a subscription-free listing service and transaction platform, Biproxi aimed to provide a comprehensive, end-to-end solution for deals under $25 million. A significant milestone was the acquisition of OfficeSpace.com in February 2020, which allowed Biproxi to consolidate its listings onto a site that was already the second-largest in the U.S. for commercial listings. Following this acquisition, the Biproxi.com site pivoted to focus exclusively on providing marketing services and tools for brokers, including property photography, data reports, and advanced digital marketing campaigns through a service called Marketing Concierge. More recently, the platform has shifted to an invitation-only network called Biproxi Capital Network, which connects vetted sponsors and developers with institutional investors to facilitate capital raises for CRE projects across various asset classes.

The company's primary clients are CRE brokers, buyers, tenants, sponsors, and investors. Revenue generation appears to be multi-pronged, initially planning to charge transaction fees to buyers and later offering financing and premium data products. The current iteration as a capital network implies revenue may be derived from connecting sponsors with capital. The platform's key features include a proprietary dataset providing valuation data on millions of off-market properties, a service known as 'biproximate™' values, and tools that allow users to list, market, and transact entirely online. This approach was designed to give independent agents and smaller brokerages the resources to compete with larger firms by offering a single platform to manage deals from listing to closing. Biproxi secured $10 million in a seed funding round in September 2019, led by Greycroft, with participation from notable entities like Newmark Knight Frank and the National Association of Realtors. Keywords: commercial real estate, CRE platform, proptech, real estate marketplace, CRE capital markets, property data, Biproxi Capital Network, real estate investment, real estate technology, Gordon Smith, OfficeSpace.com, middle-market real estate, CRE listings, real estate financing, property valuation, broker tools, real estate analytics, investment sales, deal matchmaking, institutional investors

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
New York City, United States
Employees
13
Open positions
None listed
Dealroom signal
61.3/100
Industry
Real Estate
Sector
Real Estate, Commercial Real Estate
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Biproxi.

See all news

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEEDEquity / VC Sep 2019 $10M $40M RPM Ventures · National association of realtors · Greycroft Partners
SEEDEquity / VC Sep 2018 $3M $12M Undisclosed
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Biproxi website traffic

Latest recorded traffic for Biproxi is 1.9K monthly website visits, up 11.8% over the last three months. Biproxi's team declined 18.8% over the past year.

Latest monthly visits1.9K 3-month web change+11.8% 1-year team growth-18.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Other known investors2 additional known investors

  • Reach
  • Second Century Ventures
Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States66.7%
🇨🇦 Canada16.7%
🇮🇳 India16.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Biproxi on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biproxi’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.